Medscape |
FDA approves reslizumab to treat severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com FDA has cleared reslizumab (Cinqair—Teva) for use with other asthma medicines for the maintenance treatment of severe asthma in adults. The drug is indicated for patients with a history of severe asthma attacks despite using their current asthma … FDA approves Cinqair to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma FDA Approves Teva's Asthma Injection to Treat Severe Asthma |
View full post on asthma – Google News